Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Cariboo Gold History Inspires Modern Discovery (CSE:GCC) (OTC:GCCFF) (click to learn more) Southern Energy Corp. Completes US$23.5 Million Financings and Royalty Sale (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Biostax Corporation (EM) BTAX

Healthcare Biotechnology
Biostax Corp. operates as a biopharmaceutical company that acquires, develops, and commercializes pharmaceutical and biotechnology products. Its lead investigational drug candidate Lodonal, an once-a-day immune system regulator for the management of human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS). Its programs also include Global Telehealth platform; Medtech... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (EXPM:BTAX)

Biostax Corp Announces Voluntary Delisting from OTC Pink Market and SEC Deregistration

GlobeNewswire February 21, 2025

Biostax Corp. to Participate in U.S. Business Action to End HIV Annual Coalition Meeting and World AIDS Day Reception

GlobeNewswire November 30, 2023

Biostax Announces a Director Appointment of Influential Business Leader Craig Suro

GlobeNewswire November 15, 2023

Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors

GlobeNewswire November 2, 2023

Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Treatment

GlobeNewswire October 24, 2023

Biostax Corp Announces the Passing of Esteemed Director, H. Louis Salomonsky

GlobeNewswire September 14, 2023

Biostax Corp. Signs Collaboration Agreement with Immgenuity, Inc. to Pursue Remission in HIV

GlobeNewswire August 29, 2023

Biostax Corp Announces the FDAs Acceptance of Three Investigational New Drug Applications (IND) Transfers for JKB-122 for the Treatment of NASH, NAFLD and AIH

GlobeNewswire August 15, 2023

Biostax Launches Growth Funding Round to Revitalize Affordable Healthcare

PR Newswire May 30, 2023
View More News ››

Opinion & Analysis (EXPM:BTAX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:BTAX)

Immune Therapeutics, Inc. (IMUN) Granted Approval for Lodona

Immune Therapeutics, Inc. (IMUN) Granted Approval for Lodonal™ in Nigeria   Earlier today, Immune Therapeutics, Inc. (OTCQB...
qualitystocks.net - April 27, 2016

Immune Therapeutics, Inc. (IMUN) Enters Binding Letter of In

Immune Therapeutics, Inc. (IMUN) Enters Binding Letter of Intent to Acquire Innovative CAR-T Cell Technology    Before...
qualitystocks.net - April 21, 2016

Immune Therapeutics, Inc. (IMUN) Offers Update on Methionine

Immune Therapeutics, Inc. (IMUN) Offers Update on Methionine-Enkelphine Drug Development Program in China   Before the opening...
qualitystocks.net - April 11, 2016

Immune Therapeutics, Inc. (IMUN) Steadfast in Efforts Levera

Immune Therapeutics, Inc. (IMUN) Steadfast in Efforts Leveraging the Body’s Immune System on Continent of Africa   Immune...
qualitystocks.net - March 30, 2016

Immune Therapeutics’ (IMUN) Lodonal Armors Africa against AI

Immune Therapeutics’ (IMUN) Lodonal Armors Africa against AIDS   Thought to have originated in Africa, the acquired...
qualitystocks.net - March 23, 2016

Immune Therapeutics, Inc. (IMUN) Armed with Expertise in the

Immune Therapeutics, Inc. (IMUN) Armed with Expertise in the Immune System to Fight Infectious Diseases    Immune...
qualitystocks.net - March 17, 2016
View more Bullboard ››

Avrupa Minerals Ltd.

Avrupa Minerals Ltd.

Avrupa Minerals Ltd., a junior exploration and development company, engages in the acquisition and exploration of mineral ...
View More »

Podcasts